APDN Key Statistics, Chart & Performance
The current stock price of APDN is 5.62 USD. In the past month the price increased by 142.24%. In the past year, price decreased by -97.62%.
APDN Latest News, Press Relases and Analysis
APDN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.38 | 223.10B | ||
| DHR | DANAHER CORP | 29.41 | 162.39B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 186.73 | 56.66B | ||
| A | AGILENT TECHNOLOGIES INC | 27.51 | 43.52B | ||
| IQV | IQVIA HOLDINGS INC | 19.78 | 39.10B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.29 | 30.42B | ||
| WAT | WATERS CORP | 31.77 | 24.01B | ||
| ILMN | ILLUMINA INC | 30.15 | 20.20B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.21 | 19.94B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.43 | 16.69B | ||
| TEM | TEMPUS AI INC | N/A | 13.54B | ||
| RVTY | REVVITY INC | 21.8 | 12.12B |
Related stock screener links
About APDN
Company Profile
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Company Info
APPLIED DNA SCIENCES INC
50 Health Sciences Drive
Stony Brook NEW YORK 11790 US
CEO: James A. Hayward
Employees: 47
Phone: 16312408800
APPLIED DNA SCIENCES INC / APDN FAQ
Can you describe the business of APPLIED DNA SCIENCES INC?
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
What is the current price of APDN stock?
The current stock price of APDN is 5.62 USD. The price increased by 31.62% in the last trading session.
What is the dividend status of APPLIED DNA SCIENCES INC?
APDN does not pay a dividend.
How is the ChartMill rating for APPLIED DNA SCIENCES INC?
APDN has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy APDN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on APDN.
What is APPLIED DNA SCIENCES INC worth?
APPLIED DNA SCIENCES INC (APDN) has a market capitalization of 7.25M USD. This makes APDN a Nano Cap stock.
Who owns APPLIED DNA SCIENCES INC?
You can find the ownership structure of APPLIED DNA SCIENCES INC (APDN) on the Ownership tab.
APDN Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to APDN. When comparing the yearly performance of all stocks, APDN is a bad performer in the overall market: 95.84% of all stocks are doing better.
APDN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to APDN. While APDN seems to be doing ok healthwise, there are quite some concerns on its profitability.
APDN Financial Highlights
Over the last trailing twelve months APDN reported a non-GAAP Earnings per Share(EPS) of -924.25. The EPS increased by 89.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -679.56% | ||
| ROE | -929.59% | ||
| Debt/Equity | 0 |
APDN Forecast & Estimates
For the next year, analysts expect an EPS growth of 92.97% and a revenue growth 50.26% for APDN